M. Creighton

SPECIES DIFFERENCES IN THE ELIMINATION OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST HIGHLIGHTED BY OXIDATIVE METABOLISM OF ITS ACYL GLUCURONIDE

Yuan-qing Xia, R. Franklin, C. Kochansky, 2005, Drug Metabolism and Disposition.

IDENTIFICATION AND METABOLISM OF A NOVEL DIHYDROHYDROXY-S-GLUTATHIONYL CONJUGATE OF A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONIST, MK-0767 [(±)-5-[(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL]-2-METHOXY-N-[[(4-TRIFLUOROMETHYL) PHENYL]METHYL]BENZAMIDE], IN RATS

G. Doss, R. Franklin, Vijay Bhasker G Reddy, 2004, Drug Metabolism and Disposition.

Species and gender differences in the formation of an active metabolite of a substituted 2,4-thiazolidinedione insulin sensitizer

M. Beconi, R. Franklin, N. Yu, 2003, Xenobiotica; the fate of foreign compounds in biological systems.

Identification and Metabolism of a Novel Dihydrohydroxy-S-Glutathionyl Conjugate of a PPAR Agonist, MK-0767, in Rats

G. Doss, R. Franklin, B. Karanam, 2004 .

SPECIES DIFFERENCES IN METABOLISM AND PHARMACOKINETICS OF A SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST IN RATS AND DOGS: FORMATION OF A UNIQUE GLUTATHIONE ADDUCT IN THE RAT

Y. Teffera, Wei Tang, G. Doss, 2006, Drug Metabolism and Disposition.

High-Level Resistance to Bisdioxopiperazines Catalytic Inhibitor ICRF-159 : A Tyr 49 Phe Mutation Confers Chinese Hamster Ovary Cells Resistant to the Topoisomerase II Updated

S. Kenwrick, L. Jensen, Andrew, 2006 .

Identification of novel metabolites of pioglitazone in rat and dog

R. Franklin, R. Bakhtiar, W. Feeney, 2003, Xenobiotica; the fate of foreign compounds in biological systems.

Modification of the pyridine moiety of non-peptidyl indole GnRH receptor antagonists.

M. Goulet, A. Mao, J. Cui, 2002, Bioorganic & Medicinal Chemistry Letters.